Skip to main content

Table 2 Treatment status of children/adolescents with ADHD overall and by psychiatric comorbidities in 2017

From: Prevalence of multimodal treatment in children and adolescents with ADHD in Germany: a nationwide study based on health insurance data

 

Proportion of patients with the respective treatment modality (%)

Number of patients

No treatment

Pharmacotherapy only

Psychotherapy only

Multimodal treatment

Overall

91,118

50.2

36.5

6.8

6.5

Sex

 Male

67,194

47.7

39.6

6.1

6.6

 Female

23,924

57.2

28.0

8.9

5.9

Age group in years

 3–6

7498

89.1

4.6

5.2

1.1

 7–9

22,298

61.0

25.6

7.6

5.7

 10–12

26,139

44.7

39.9

7.6

7.8

 13–17

35,183

39.0

47.7

6.2

7.1

Selected psychiatric comorbidities

 Depressive disorders (F32, F33, F41.2, F43.2)

11,651

36.2

31.9

18.0

14.0

 Tic disorders (F95)

3030

41.2

40.6

8.0

10.2

 Pervasive developmental disorders (F84.0, F84.1, F84.5, F84.8, F84.9)

5107

42.3

43.6

5.9

8.3

 Conduct disorders (F90.1, F91, F92)

25,804

34.3

44.3

9.3

12.2

 Phobic anxiety disorders (F40, F41.0, F41.1, F41.3, F41.8, F41.9, F93)

17,194

39.3

33.3

15.1

12.3

Number of psychiatric comorbiditiesa

 0

22,933

56.8

38.4

2.5

2.2

 1

26,200

52.1

36.7

5.9

5.3

 2

19,700

48.3

35.8

8.1

7.8

  ≥ 3

22,285

42.7

35.0

11.2

11.1

  1. Percentages are row percentages
  2. aExclusively related to the 22 comorbidities mentioned in Table 1